MCMatthew A. Cranswick

Matthew A. Cranswick

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Matthew A. Cranswick has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Scalable Flow Synthesis of Genetically Encodable Tetrazine Amino Acids

    by Yogesh M. Gangarde, Erik C. Carlson, Matthew A. Cranswick, Ryan A. Mehl

    The tetrazine–cyclooctene ligation is among the fastest bioorthogonal reactions known, enabling rapid and selective bioconjugation. Site-specific incorporation of tetrazine-bearing noncanonical amino acids (Tet-ncAAs) into proteins via genetic code expansion has expanded the toolkit for applications in chemical biology, therapeutic conjugation, and live-cell imaging. However, existing synthetic routes to Tet-ncAAs rely on small-scale batch reactions that rely on hazardous reagents and are poorly suited for scale-up. Here, we report both a hybrid batch-flow and continuous flow synthetic approaches for Tet-ncAAs that improve process safety, scalability, and reproducibility. The use of aqueous hydrazine in place of anhydrous hydrazine, 3-mercaptopropionic acid as an organic catalyst in place of metal salts, and a compatible solvent system enables the synthesis under safer, milder, and environmentally-friendly conditions. Optimization of the temperature for the reaction revealed a two-step process involving rapid hydrazine addition followed by cyclization at a lower temperature. This modular process supports multigram-scale synthesis of diverse Tet-ncAAs from commercial precursors and integrates a fully continuous oxidation protocol to access the final tetrazine products. The resulting platform offers a safer, scalable, and sustainable route to Tet-ncAAs that supports the growing demand in antibody–drug conjugates, radioimmunoconjugates, antibody–oligonucleotide and protein–protein conjugates as well as protein labeling and targeted delivery applications.

  • Tuning enantioselective drug adsorption in isoreticular homochiral metal–peptide frameworks through proximity pore interactions

    by James Ho, Ankit K. Yadav, Andrzej Gładysiak, Andrew P. Carpenter, Anjali Verma, Matthew A. Cranswick, Adrian Henle, Mas A. Subramanian, Joe Baio, Kyriakos C. Stylianou

    Homochiral MOFs with tunable pore sizes enable controlled adsorption of racemic drugs, achieving up to 76.1% enantiomeric excess for l -penicillamine through proximity-driven interactions.

  • Open Access

    Mechanistic Distinction Between Oxidative and Chlorination Transformations of Chloroperoxidase from Caldariomyces fumago Demonstrated by Dye Decolorization

    by Norman Paz-Ramirez, Jacob Redwinski, Matthew A. Cranswick, Kyle A. Grice, Kari L. Stone

    Effluents from the textile industry, particularly those containing synthetic azo dyes, poses a significant environmental threat, necessitating the development of more effective and sustainable pollutant removal methods. Traditional dye removal techniques often fall short in efficiency and environmental impact, prompting the exploration of enzymatic degradation as a promising alternative. This study focuses on chloroperoxidase, a natural biocatalyst recognized for its ability to oxidize synthetic dyes into less harmful products. By exploring the mechanistic distinction between chlorination and oxidative processes, we investigate the enzyme’s specific degradation pathways for azo dyes and the resulting by-products. Utilizing analytical techniques, including liquid chromatography/mass spectrometry (LC/MS), and density functional theory (DFT), we gain insights into the decolorization mechanism, revealing that the enzyme preferentially generates oxidative products through C–N bond cleavage as its initial degradation step. These findings underscore not only the unique mechanistic properties of chloroperoxidase but also its potential as a biocatalyst for industrial applications. This study advocates further research into the optimization of enzyme-based systems, highlighting their relevance in advancing greener chemical practices in the textile industry, thus contributing to more sustainable manufacturing processes.


  • Open Access

    Engaging chemistry educators through virtual roundtables: how the COVID-19 pandemic led to a community-wide initiative

    by M. Taylor Haynes, Justin M. Pratt, Matthew A. Cranswick, Kyle A. Grice, Chip Nataro, Sarah E. Shaner, Kari L. Stone, Meghan Porter, Jeffrey R. Raker

    Members of the Interactive Online Network of Inorganic Chemists (IONiC) report the development and sustained efforts to provide virtual professional development sessions: Supporting Learning with Interactive Teaching: a Hosted, Engaging Roundtable (SLiThEr). SLiThEr’s emerged from a community need at the start of the COVID-19 pandemic; since then, SLiThEr’s have become a standard event for the IONiC community. SLiThEr’s are real- time virtual community events, after which a recording of the SLiThEr is posted on the IONiC YouTube channel. In this paper, an overview of the structure, format, and emergence of SLiThEr’s is reported, followed by evaluation of SLiThEr offerings, a plan for future SLiThEr offerings, and a discussion of how SLiThEr’s impact teaching practice. Graphical Abstract


  • Open Access

    Tuning Enantioselective Drug Adsorption in Isoreticular Homochiral Metal-Peptide Frameworks through Proximity Pore Interactions

    by James Ho, Ankit Yadav, Andrzej Gładysiak, Andrew Carpenter, Anjali Verma, Matthew Cranswick, Adrian Henle, Mas Subramanian, Joe Baio, Kyriakos Stylianou

    Pharmaceutical research places great importance on the stereochemistry and enantioseparation of racemic drugs due to the potential variations in pharmacological and toxicological properties displayed by different enantiomers as they interact with the body’s metabolic pathway. Metal-organic frameworks (MOFs) are porous adsorbents that can be designed to possess homochirality within their structures, enabling tunable porosity and enantioselective adsorption. In our study, we present the synthesis of five novel and homochiral Co-L-GG(R) MOFs (where L-GG = glycyl-L(S)-glutamic acid and R = bipyridyl (bipy) pillar ligands). These isoreticular MOFs were synthesized using the ligand extension strategy. This approach allowed us to systematically control the pore sizes of the MOFs, enabling fine-tuning of the enantioselective adsorption of racemic drugs, primarily DL-Penicillamine (Pen). Our findings reveal that the pore size greatly influences enantioselective adsorption, where too large or too small pores hinder the proximity-driven dispersive interactions between the drug and the pore surface, resulting in poor enantioselective adsorption of Pen. We achieved an enantiomeric excess (ee) of 60.1% (L over D), increasing to a maximum 76.1% ee using Co-L-GGvinylbipy by tuning proximity interactions in saturated pores. These results were accomplished by controlling the drug saturation within the MOF pores, promoting favorable interactions.

  • Open Access

    A greener tetraphenylporphyrin synthesis and metallation: an undergraduate teaching experiment

    by Matthew A. Nitka, Katarina E. Zerbee, Julianne M. Dee, Matthew A. Cranswick, Edward P. Zovinka, John R. De Backere

    While porphyrin-related syntheses have become classic experiments in the undergraduate curriculum, traditional syntheses of the free-base meso-tetraphenylporphyrin (H2TPP) and its metallated derivatives can be energy-intensive, use hazardous solvents, and generate appreciable amounts of waste. In an attempt to make the synthesis of H2TPP and its metallated derivatives (MTPP where M = metal) better aligned with the principles of green chemistry, we optimized a microwave-assisted, microscale synthesis of H2TPP and alternative routes toward the metallation of H2TPP including solvent-substituted reflux and mechanochemical syntheses for the undergraduate teaching laboratory. The greenness of these syntheses were evaluated using various green metrics and qualitative comparison to previously reported syntheses.


  • Oxoiron(IV) Complex of the Ethylene-Bridged Dialkylcyclam Ligand Me2EBC

    by Jason England, Jai Prakash, Matthew A. Cranswick, Debasish Mandal, Yisong Guo, Eckard Münck, Sason Shaik, Lawrence Que

    We report herein the first example of an oxoiron(IV) complex of an ethylene-bridged dialkylcyclam ligand, [FeIV(O)(Me2EBC)(NCMe)]2+ (2; Me2EBC = 4,11-dimethyl-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane). Complex 2 has been characterized by UV–vis, 1H NMR, resonance Raman, Mössbauer, and X-ray absorption spectroscopy as well as electrospray ionization mass spectrometry, and its properties have been compared with those of the closely related [FeIV(O)(TMC)(NCMe)]2+ (3; TMC = 1,4,8,11-tetramethyl-1,4,8,11-tetraazacyclotetradecane), the intensively studied prototypical oxoiron(IV) complex of the macrocyclic tetramethylcyclam ligand. Me2EBC has an N4 donor set nearly identical with that of TMC but possesses an ethylene bridge in place of the 1- and 8-methyl groups of TMC. As a consequence, Me2EBC is forced to deviate from the trans-I configuration typically found for FeIV(O)(TMC) complexes and instead adopts a folded cis-V stereochemistry that requires the MeCN ligand to coordinate cis to the FeIV═O unit in 2 rather than in the trans arrangement found in 3. However, switching from the trans geometry of 3 to the cis geometry of 2 did not significantly affect their ground-state electronic structures, although a decrease in ν(Fe═O) was observed for 2. Remarkably, despite having comparable FeIV/III reduction potentials, 2 was found to be significantly more reactive than 3 in both oxygen-atom-transfer (OAT) and hydrogen-atom-transfer (HAT) reactions. A careful analysis of density functional theory calculations on the HAT reactivity of 2 and 3 revealed the root cause to be the higher oxyl character of 2, leading to a stronger O---H bond specifically in the quintet transition state.


  • H2O2activation with biomimetic non-haem iron complexes and AcOH: connecting the g = 2.7 EPR signal with a visible chromophore

    by Olga V. Makhlynets, Williamson N. Oloo, Yurii S. Moroz, Irina G. Belaya, Taryn D. Palluccio, Alexander S. Filatov, Peter Müller, Matthew A. Cranswick, Lawrence Que, Elena V. Rybak-Akimova

    Mechanistic studies of H2O2 activation by complexes related to [(BPMEN)FeII(CH3CN)2]2+ with electron-rich pyridines revealed that a new intermediate formed in the presence of acetic acid with a 465 nm visible band can be associated with an unusual g = 2.7 EPR signal. We postulate that this chromophore is an acylperoxoiron(III) intermediate.


  • Protonation of a Peroxodiiron(III) Complex and Conversion to a Diiron(III/IV) Intermediate: Implications for Proton-Assisted O–O Bond Cleavage in Nonheme Diiron Enzymes

    by Matthew A. Cranswick, Katlyn K. Meier, Xiaopeng Shan, Audria Stubna, Jószef Kaizer, Mark P. Mehn, Eckard Münck, Lawrence Que

    Oxygenation of a diiron(II) complex, [FeII2(μ-OH)2(BnBQA)2(NCMe)2]2+ [2, where BnBQA is N-benzyl-N,N-bis(2-quinolinylmethyl)amine], results in the formation of a metastable peroxodiferric intermediate, 3. The treatment of 3 with strong acid affords its conjugate acid, 4, in which the (μ-oxo)(μ-1,2-peroxo)diiron(III) core of 3 is protonated at the oxo bridge. The core structures of 3 and 4 are characterized in detail by UV–vis, Mössbauer, resonance Raman, and X-ray absorption spectroscopies. Complex 4 is shorter-lived than 3 and decays to generate in ∼20% yield of a diiron(III/IV) species 5, which can be identified by electron paramagnetic resonance and Mössbauer spectroscopies. This reaction sequence demonstrates for the first time that protonation of the oxo bridge of a (μ-oxo)(μ-1,2-peroxo)diiron(III) complex leads to cleavage of the peroxo O–O bond and formation of a high-valent diiron complex, thereby mimicking the steps involved in the formation of intermediate X in the activation cycle of ribonucleotide reductase.